Cite
HARVARD Citation
Li, Y. et al. (2019). An Open‐Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics. Clinical pharmacology in drug development. 8 (3), pp. 346-354. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, Y. et al. (2019). An Open‐Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics. Clinical pharmacology in drug development. 8 (3), pp. 346-354. [Online].